Aarben Biotech Private Limited

Founded in 2011 and headquartered in Gujarat, India.

2011 | Surat, Gujarat (India) | Inactive
Last Updated: February 15, 2025

Aarben Biotech Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth -7.90%
  • Profit Growth -139.52%
  • Ebitda 24.05%
  • Net Worth -0.80%
  • Total Assets

About Aarben Biotech

Aarben Biotech Private Limited (ABPL) is Strike Off company established on 02 May 2011 with its office registered at Surat, Gujarat, India and has been running since 13 Year, 9 Months with a paid up capital of 0.10 M. According to MCA records, 3 Directors are linked to this company as of 15 Feb 2025.

Company Details

  • Location

    Surat, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239GJ2011PTC065249

  • Company No.

    065249

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    02 May 2011

  • Date of AGM

    30 Sep 2017

  • Date of Balance Sheet

    31 Mar 2017

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Trading

Who are the key members and board of directors at Aarben Biotech?

Board Members (3)

NameDesignationAppointment DateStatus
Birendra Prasad Country flag representing In Director 02-May-2011Current
Om Kushwaha Country flag representing In Director 02-May-2011Current
Meena Pandey Country flag representing In Director 06-Aug-2011Current

Financial Performance of Aarben Biotech.

Aarben Biotech Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 7.9% decrease. The company also saw a substantial fall in profitability, with a 139.52% decrease in profit. The company's net worth dipped by a decrease of 0.8%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-7.90%
Revenue from Operations
-7.90%
Total Assets
Profit or Loss
-139.52%
Net Worth
-0.80%
EBITDA
24.05%

What is the Ownership and Shareholding Structure of Aarben Biotech?

In 2017, Aarben Biotech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Aarben Biotech?

Unlock and access historical data on people associated with Aarben Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aarben Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarben Biotech's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Aarben Biotech

Recent activity within the organization

  • Annual General Meeting

    Aarben Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.

    30 Sep 2017

  • Balance Sheet

    Aarben Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad.

    31 Mar 2017

  • Director Appointment

    Meena Pandey was appointed as a Director was appointed as a Director on 06 Aug 2011 & has been associated with this company since 13 years 6 months .

    06 Aug 2011

  • Director Appointment

    Birendra Prasad was appointed as a Director was appointed as a Director on 02 May 2011 & has been associated with this company since 13 years 9 months .

    02 May 2011

  • Director Appointment

    Om Prakash Kushwaha was appointed as a Director was appointed as a Director on 02 May 2011 & has been associated with this company since 13 years 9 months .

    02 May 2011

  • Company Incorporation

    Aarben Biotech Private Limited was registered on 02 May 2011 with Roc Ahmedabad & aged 13 years 9 months as per MCA records.

    02 May 2011

Frequently asked questions

  • Aarben Biotech Private Limited was incorporated on 02 May 2011.

  • The authorized share capital of Aarben Biotech Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Aarben Biotech Private Limited.

    • Birendra Prasad
    • Om Prakash Kushwaha
    • Meena Pandey
  • As per Ministry of Corporate Affairs (Mca), the registered address of Aarben Biotech Private Limited is Aagam Navkar Appartment K-204 2Nd Floor Behind Sachin Railway Station, Kansad India, Surat, Gujarat, 394235.

  • The corporate identification number (CIN) of Aarben Biotech Private Limited is U24239GJ2011PTC065249 and the company number is 065249 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2017, the revenue trend for Aarben Biotech Private Limited has fallen by -7.90%.

  • The financial reports for the fiscal year 2017 indicates that The net worth of Aarben Biotech Private Limited has experienced an downturn of -0.80%.

  • The most recent Balance Sheet for Aarben Biotech Private Limited was filed with the ROC on 31 Mar 2017.

People also Viewed

Similar Companies Based on Retail Trading